{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["27(Suppl 2)"],"submitter":["Pascal H"],"journal":["Annals of oncology : official journal of the European Society for Medical Oncology"],"pagination":["ii78-ii79"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4984058"],"repository":["biostudies-literature"],"pubmed_title":["P-272The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)"],"pmcid":["PMC4984058"],"pubmed_authors":["Louis K","Philip P","Alberto S","Jill L","Pascal H","Fabienne P","Eric T","Fernando R","Scot D","Thomas N","Luis M","Beatriz G","Edward K","Venu B","Jamil A","Jack S"],"additional_accession":[]},"is_claimable":false,"name":"P-272The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)","description":null,"dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Jun","modification":"2025-04-26T20:34:07.963Z","creation":"2025-04-06T16:26:14.851Z"},"accession":"S-EPMC4984058","cross_references":{}}